In the context of chronic liver diseases, including MASLD and alcoholic hepatitis, persistent heightened activity of the cGAS-STING cascade can exacerbate hepatic inflammation, potentially accelerating disease advancement and even fostering HCC development. Here, STING1 is linked to hepatocellular carcinoma.